Patent application number | Description | Published |
20090043645 | METHOD AND SYSTEM FOR ELECTRONIC DISTRIBUTION OF PRODUCT REDEMPTION COUPONS - Provided is a method and system for the electronic distribution of product redemption coupons to remote personal computers located at users' homes. A centrally located repository, such as an online service provider or web site on the Internet, stores packages of coupon data for downloading on demand to the user's computer. The user may view, select, sort and print desired coupons from the downloaded package. The user's demographic as well as coupon selection data is provided back to the online service and coupon distributor and issuers for subsequent marketing analysis. The online service can perform subsequent coupon processing on previously downloaded coupon packages such as variation of discount amounts. The online service provider can also determine how many times a particular coupon was viewed. When the printed coupons are presented at a retail store, the discount is provided to the user. Upon redemption by the store via a coupon redeeming center, transaction data is also supplied to the coupon issuers and distributor for integration into marketing analysis. The electronic coupon system is secure due to the inclusion of user-specific identification indicia printed thereon. | 02-12-2009 |
20140236690 | METHOD AND SYSTEM FOR ELECTRONIC DISTRIBUTION OF PRODUCT REDEMPTION COUPONS - Provided is a method and system for the electronic distribution of coupons to user devices. A repository, such as an online service provider, stores packages of coupon data for downloading on demand. The user may view, select, and sort desired coupons. The user's demographic as well as coupon selection data is provided back to the online service and coupon distributor and issuers for subsequent marketing analysis. The online service can perform subsequent coupon processing on previously downloaded coupon packages such as variation of discount amounts and can also determine how many times a particular coupon was viewed. When coupons are presented at a retail store, the discount is provided to the user. Upon redemption by the store, transaction data is also supplied to the coupon issuers and distributor for integration into marketing analysis. | 08-21-2014 |
20140244370 | METHOD AND SYSTEM FOR ELECTRONIC DISTRIBUTION OF PRODUCT REDEMPTION COUPONS - Provided is a method and system for the electronic distribution of product redemption coupons to remote personal computers located at users' homes. A centrally located repository, such as an online service provider or web site on the Internet, stores packages of coupon data for downloading on demand to the user's computer. The user may view, select, sort and print desired coupons from the downloaded package. The user's demographic as well as coupon selection data is provided back to the online service and coupon distributor and issuers for subsequent marketing analysis. The online service can perform subsequent coupon processing on previously downloaded coupon packages such as variation of discount amounts. The online service provider can also determine how many times a particular coupon was viewed. When the printed coupons are presented at a retail store, the discount is provided to the user. Upon redemption by the store via a coupon redeeming center, transaction data is also supplied to the coupon issuers and distributor for integration into marketing analysis. The electronic coupon system is secure due to the inclusion of user-specific identification indicia printed thereon. | 08-28-2014 |
20140244383 | METHOD AND SYSTEM FOR ELECTRONIC DISTRIBUTION OF PRODUCT REDEMPTION COUPONS - Provided is a method and system for the electronic distribution of product redemption coupons to remote personal computers located at users' homes. A centrally located repository, such as an online service provider or web site on the Internet, stores packages of coupon data for downloading on demand to the user's computer. The user may view, select, sort and print desired coupons from the downloaded package. The user's demographic as well as coupon selection data is provided back to the online service and coupon distributor and issuers for subsequent marketing analysis. The online service can perform subsequent coupon processing on previously downloaded coupon packages such as variation of discount amounts. The online service provider can also determine how many times a particular coupon was viewed. When the printed coupons are presented at a retail store, the discount is provided to the user. Upon redemption by the store via a coupon redeeming center, transaction data is also supplied to the coupon issuers and distributor for integration into marketing analysis. The electronic coupon system is secure due to the inclusion of user-specific identification indicia printed thereon. | 08-28-2014 |
Patent application number | Description | Published |
20120154054 | APPARATUS AND METHODS FOR OSCILLATION SUPPRESSION - Apparatus and methods for oscillation suppression are disclosed. In one embodiment, a power amplifier system includes a plurality of power amplifiers for amplifying an input radio frequency (RF) signal to generate an output RF signal. The plurality of power amplifiers include a first power amplifier, a second power amplifier, and a third power amplifier, each of which are configured to be individually switchable between an enabled state and a disabled state so as to control a power amplification of the power amplifier system. A first capacitor is electrically connected between the outputs of the first and second power amplifiers, and a second capacitor is electrically connected between the outputs of the second and third power amplifiers. The first and second capacitors are configured to allow signals generated using the first, second, and third power amplifiers to combine constructively to generate the output RF signal. | 06-21-2012 |
20120235737 | APPARATUS AND METHODS FOR CAPACITIVE LOAD REDUCTION - Apparatus and methods for capacitive load reduction are disclosed. In one embodiment, a power amplifier system includes a power amplifier configured to amplify a radio frequency (RF) signal of a first frequency and an envelope tracker configured to control a supply voltage of the power amplifier using an envelope of the RF signal. The power amplifier system further includes an inductor electrically connected between the power amplifier and the envelope tracker and a capacitor electrically connected between the power amplifier and the envelope tracker. The capacitor and the inductor are configured to have a resonance near the first frequency. | 09-20-2012 |
20140203878 | APPARATUS AND METHODS FOR REDUCING CAPACITIVE LOADING OF A POWER AMPLIFIER SUPPLY CONTROL MODULE - Apparatus and methods for reducing capacitive loading of a power amplifier supply control module are disclosed. In one embodiment, a method of power supply control in a power amplifier system includes controlling a voltage level of a supply voltage using a supply control module, amplifying a first radio frequency (RF) signal using a first power amplifier module, amplifying a second RF signal using a second power amplifier module, delivering the supply voltage to a first supply input of the first power amplifier module through a first resonant circuit, and delivering the supply voltage to a second supply input of the second power amplifier module through a second resonant circuit. The first resonant circuit includes a first inductor and a first capacitor electrically connected in parallel, and the second resonant circuit includes a second inductor and a second capacitor electrically connected in parallel. | 07-24-2014 |
20140213201 | CIRCUITS AND METHODS FOR REDUCING INSERTION LOSS EFFECTS ASSOCIATED WITH RADIO-FREQUENCY POWER COUPLERS - Disclosed are circuits and methods for reducing insertion loss effects associated with radio-frequency (RF) power couplers. In some implementations, an RF circuit can include a first path configured to route a first RF signal in a first band, and a second path configured to route a second RF signal in a second band. The RF circuit can further include a power detector having a first coupler configured to detect power along the first path, and a second coupler configured to detect power along the second path. The first coupler and the second couplers can be connected in a daisy-chain configuration. The RF circuit can further include an adjustment circuit implemented along at least one of the first path and the second paths. The adjustment circuit can be configured to move a frequency response feature associated with the power detector to a different frequency range. | 07-31-2014 |
20140320205 | AUTOTRANSFORMER-BASED IMPEDANCE MATCHING CIRCUITS AND METHODS FOR RADIO-FREQUENCY APPLICATIONS - Disclosed are devices and methods related to autotransformer-based impedance matching for radio-frequency (RF) applications. In some embodiments, an impedance matching device can include a primary metal trace and a secondary metal trace, each having a respective number of turns. Such metal traces can be interconnected to form an autotransformer with the primary metal trace and the secondary metal trace being in respective planes separated by a selected distance. Such an autotransformer can be utilized to, for example, facilitate impedance matching of an amplified RF signal from a power amplifier (PA). In some embodiments, the impedance matching device can be implemented as an integrated passive device (IPD) mountable on a packaging substrate. Such an IPD can be configured to allow stacking of another component on the IPD to yield a number of desirable features in products such as RF modules. | 10-30-2014 |
20140320252 | LOW LOSS IMPEDANCE TRANSFORMERS IMPLEMENTED AS INTEGRATED PASSIVE DEVICES AND RELATED METHODS THEREOF - Disclosed are apparatus and methods related to low loss impedance transformers implemented as integrated passive devices (IPDs). In some embodiments, an IPD can include an autotransformer implemented within a body. The autotransformer can include primary and secondary metal traces implemented in respective planes separated by a distance. The autotransformer can be configured to, for example, facilitate impedance matching of radio-frequency (RF) signals. In some embodiments, the IPD can include a surface that allows mounting of one or more components thereon to provide space savings in RF modules. Examples of fabrication methods as well as products that can benefit from such IPDs are disclosed. | 10-30-2014 |
Patent application number | Description | Published |
20090232774 | Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance - The present invention provides a method of treating a disease in a subject in need thereof via non-syngeneic graft administration without or with reduced concomitant graft rejection. The method comprises administering to the subject a therapeutically effective graft being non-syngeneic with the subject, and a dose of tolerogenic cells being non-syngeneic with both the subject and the graft for preventing or reducing graft rejection in the subject, thereby treating the disease in the subject | 09-17-2009 |
20090324607 | Therapeutic Transplantation Using Developing, Human or Porcine, Renal or Hepatic, Grafts - A method of treating a renal, hepatic or enzyme-deficiency disorder in a subject in need thereof is disclosed. The method is effected by transplanting into the subject tissue derived from a human or porcine, kidney or liver, the kidney or liver being at a selected gestational stage. | 12-31-2009 |
20100021433 | Disease treatment via developing non-syngeneic graft transplantation - A method of providing a pancreatic, lymphoid/hematopietic or pulmonary organ and/or tissue function to a mammalian subject is provided. The method comprises transplanting into the subject a developing mammalian pancreatic, lymphoid/hematopietic or pulmonary organ/tissue graft, respectively, thereby generating a functional pancreatic, lymphoid/hematopietic or pulmonary organ and/or tissue, respectively, for providing the pancreatic, lymphoid/hematopietic or pulmonary organ and/or tissue function, respectively, to the subject. | 01-28-2010 |
20100221270 | THERAPEUTIC TRANSPLANTATION USING DEVELOPING, HUMAN OR PORCINE, RENAL OR HEPATIC, GRAFTS - A method of treating a renal, hepatic or enzyme-deficiency disorder in a subject in need thereof is disclosed. The method is effected by transplanting into the subject tissue derived from a human or porcine, kidney or liver, the kidney or liver being at a selected gestational stage. | 09-02-2010 |
20110212071 | ANTI THIRD PARTY CENTRAL MEMORY T CELLS, METHODS OF PRODUCING SAME AND USE OF SAME IN TRANSPLANTATION AND DISEASE TREATMENT - An isolated population of cells comprising non-GVHD inducing anti-third party cells having a central memory T-lymphocyte (Tcm) phenotype is provided. The cells being tolerance-inducing cells and capable of homing to the lymph nodes following transplantation. Methods of generating same, use of same and methods of treatment are also provided. | 09-01-2011 |
20110236405 | COAGULATION FACTOR MODULATION FOR CONTROLLING TRANSPLANT ORGAN SIZE - A method of modulating transplant organ size in a subject in need thereof is disclosed. The method comprising: (a) administering to the subject an agent capable of modulating an activity or expression of a coagulation factor or an effector thereof; and (b) transplanting the organ into the subject; thereby modulating the transplant organ size in the subject. | 09-29-2011 |
20120189574 | METHODS FOR HEMATOPOIETIC PRECURSOR MOBILIZATION - Methods of modulating mobilization of cells from the bone marrow are provided. In a specific embodiment there is provided a method of increasing mobilization of hematopoietic precursors from the bone marrow to the peripheral blood in a subject in need thereof, the method comprising: (a) administering to the subject an agent which downregulates an activity or expression of a coagulation factor or an effector thereof; and (b) harvesting the hematopoietic precursors from the peripheral blood. | 07-26-2012 |
20130171108 | USE OF ANTI THIRD PARTY CENTRAL MEMORY T CELLS FOR ANTI-LEUKEMIA/LYMPHOMA TREATMENT - A method of treating a disease in a subject in need thereof is disclosed. The method comprising: (a) transplanting a non-syngeneic cell or tissue graft to the subject; and (b) administering to the subject a therapeutically effective amount of an isolated population of cells comprising non-graft versus host (GVHD) inducing anti-third party cells having a central memory T-lymphocyte (Tcm) phenotype, the cells being tolerance-inducing cells and capable of homing to the lymph nodes following transplantation, and further wherein the cells are either: (i) non-syngeneic with both the subject and the graft; or (ii) non-syngeneic with the graft and syngeneic with the subject, thereby treating the subject. | 07-04-2013 |
20130183322 | IMMUNOSUPPRESSIVE DRUG COMBINATION FOR A STABLE AND LONG TERM ENGRAFTMENT - A method of treating a subject in need of a cell or tissue transplant is disclosed. The method comprising (a) transplanting a non-syngeneic cell or tissue transplant into the subject, wherein the transplant comprises bone marrow or lymphoid cells; and (b) administering to the subject a therapeutically effective amount of an immunosuppressive regimen comprising a Sphingosine 1-Phosphate Receptor Agonist, a B7 molecule inhibitor and a CD2/CD58 pathway inhibitor, thereby treating the subject. | 07-18-2013 |
20140212398 | ANTI THIRD PARTY CENTRAL MEMORY T CELLS, METHODS OF PRODUCING SAME AND USE OF SAME IN TRANSPLANTATION AND DISEASE TREATMENT - A method of generating an isolated population of cells comprising anti-third party cells having a central memory T-lymphocyte (Tcm) phenotype, the cells being tolerance-inducing cells and/or endowed with anti-disease activity, and capable of homing to the lymph nodes following transplantation is disclosed. The method comprising: (a) contacting peripheral blood mononuclear cells (PBMC) with a third party antigen or antigens in the presence of IL-21 so as to allow enrichment of antigen reactive cells; and (b) culturing the cells resulting from step (a) in the presence of IL-21, IL-15 and IL-7 in an antigen free environment so as to allow proliferation of cells comprising the central memory T-lymphocyte (Tcm) phenotype. | 07-31-2014 |
20140356335 | MAMMALIAN FETAL PULMONARY CELLS AND THERAPEUTIC USE OF SAME - A pharmaceutical composition comprising as an active ingredient an isolated population of cell suspension from a mammalian fetal pulmonary tissue is disclosed. The fetal pulmonary tissue is at a developmental stage corresponding to that of a human pulmonary organ/tissue at a gestational stage selected from a range of about 20 to about 22 weeks of gestation. Methods of using the pharmaceutical composition are also disclosed. | 12-04-2014 |
20140363437 | COMBINATION THERAPY FOR A STABLE AND LONG TERM ENGRAFTMENT - A method of treating a subject in need of a non-syngeneic cell or tissue graft is disclosed. The method comprising: (a) transplanting into a subject a dose of T cell depleted immature hematopoietic cells, wherein the T cell depleted immature hematopoietic cells comprise less than 5×10 | 12-11-2014 |
20140369974 | COMBINATION THERAPY FOR A STABLE AND LONG TERM ENGRAFTMENT USING SPECIFIC PROTOCOLS FOR T/B CELL DEPLETION - A method of treating a subject in need of a non-syngeneic cell or tissue graft is disclosed. The methos comprising: (a) transplanting into a subject a dose of T cell depleted immature hematopoetic cells, wherein the T cell depleted immature hematopoetic cells comprise less than 5×105 CD3+ T cells per kilogram body weight of the subject, and wherein the dose comprises at least about 5×106 CD34+ cells per kilogram body weight of the subject, and wherein the T cell depleted immature hematopoetic cells are obtained by separating the T cells from the immature hematopoetic cells by magnetic cell sorting, and (b) administering to the subject a therapeutically effective amount of cyclophosphamide, wherein the therapeutically effective amount comprises 25-200 mg per body weight, thereby treating the subject. | 12-18-2014 |
20150010512 | Disease treatment via developing non-syngeneic graft transplantation - A method of providing a pancreatic, lymphoid/hematopietic or pulmonary organ and/or tissue function to a mammalian subject is provided. The method comprises transplanting into the subject a developing mammalian pancreatic, lymphoid/hematopietic or pulmonary organ/tissue graft, respectively, thereby generating a functional pancreatic, lymphoid/hematopietic or pulmonary organ and/or tissue, respectively, for providing the pancreatic, lymphoid/hematopietic or pulmonary organ and/or tissue function, respectively, to the subject. | 01-08-2015 |
20150104471 | UNIVERSAL DONOR-DERIVED TOLEROGENIC CELLS FOR INDUCING NON-SYNGENEIC TRANSPLANTATION TOLERANCE - The present invention provides a method of treating a disease in a subject in need thereof via non-syngeneic graft administration without or with reduced concomitant graft rejection. The method comprises administering to the subject a therapeutically effective graft being non-syngeneic with the subject, and a dose of tolerogenic cells being non-syngeneic with both the subject and the graft for preventing or reducing graft rejection in the subject, thereby treating the disease in the subject | 04-16-2015 |
20150174294 | DISEASE TREATMENT VIA DEVELOPING NON-SYNGENEIC GRAFT TRANSPLANTATION - A method of providing a pancreatic, lymphoid/hematopietic or pulmonary organ and/or tissue function to a mammalian subject is provided. The method comprises transplanting into the subject a developing mammalian pancreatic, lymphoid/hematopietic or pulmonary organ/tissue graft, respectively, thereby generating a functional pancreatic, lymphoid/hematopietic or pulmonary organ and/or tissue, respectively, for providing the pancreatic, lymphoid/hematopietic or pulmonary organ and/or tissue function, respectively, to the subject. | 06-25-2015 |
20150190546 | THERAPEUTIC TRANSPLANTATION USING DEVELOPING, HUMAN OR PORCINE, RENAL OR HEPATIC, GRAFTS - A method of treating a renal, hepatic or enzyme-deficiency disorder in a subject in need thereof is disclosed. The method is effected by transplanting into the subject tissue derived from a human or porcine, kidney or liver, the kidney or liver being at a selected gestational stage. | 07-09-2015 |
Patent application number | Description | Published |
20100305392 | THORACIC AORTA AND VAGUS NERVE STIMULATION - Apparatus and methods are described including identifying a subject as suffering from a condition selected from the group consisting of congestive heart failure, diastolic heart failure, and hypertension. In response to the identifying, an electrode is placed on a vagus nerve of the subject at a vagal site that is between (a) a vagal bifurcation with a thoracic cardiac branch of the subject, and (b) thoracic vagal branching into the esophageal plexus of the subject. The subject is treated by driving a current into the vagal site, via the electrode. Other embodiments are also described. | 12-02-2010 |
20110137370 | THORACIC AORTA AND VAGUS NERVE STIMULATION - Apparatus and methods are provided, including an electrode that is placed in contact with an artery of a subject. A control unit drives the electrode to perform a function with respect to the artery, the function selected from the group consisting of: driving a current into the artery, and sensing an electrical parameter of the artery. A transmitter is placed in a vein of the subject that is in a vicinity of the artery, the transmitter being wiredly connected to the control unit. The control unit is configured to drive the electrode by wirelessly transmitting a signal via the transmitter. Other embodiments are also described. | 06-09-2011 |
20120035679 | ACUTE MYOCARDIAL INFARCTION TREATMENT BY ELECTRICAL STIMULATION OF THE THORACIC AORTA - Apparatus and methods are described including identifying a subject as suffering from a condition selected from the group consisting of congestive heart failure, diastolic heart failure, acute myocardial infarction, and hypertension. In response to the identifying, an electrode is placed on the subject's aorta at an aortic site that is between a bifurcation of the aorta with the subject's left subclavian artery and a bifurcation of the aorta with the subject's fifth intercostal artery. The subject is treated by electrically stimulating the aortic site by driving a current into the aortic site, via the electrode. Other applications are also described. | 02-09-2012 |
20120035711 | ENHANCING PERFUSION BY CONTRACTION - Apparatus and methods are described including a mechanical support element that is placed inside a first vein of a subject. At least one electrode disposed on the mechanical support element is placed inside the first vein, in a vicinity of a site upstream of a bifurcation with a second vein of the subject. A control unit enhances downstream blood flow from the first vein by driving the at least one electrode to divert blood downstream into the second vein by constricting the first vein at the upstream site, by driving the at least one electrode to apply a current to the vicinity of the site. The mechanical support element prevents the first vein from collapsing by providing mechanical support to the vein. Other embodiments are also described. | 02-09-2012 |
20120158081 | PACEMAKER WITH NO PRODUCTION - Apparatus and methods are provided for use with a heart of a subject, including a set of one or more electrodes. A control unit paces the heart by driving a first electric current via the electrode set into tissue of the subject, in accordance with a first set of parameters. The control unit stimulates nitric oxide production by a portion of the heart by driving a second electric current via the electrode set into the portion of the heart, in accordance with a second set of parameters. Other embodiments are also described. | 06-21-2012 |
20130123880 | DETECTOR-BASED AORTIC STIMULATION - Apparatus is provided, including (1) an external device, configured for placement outside of a body of a subject and to sense a factor of the subject, and to generate a signal in response to the sensed factor, and (2) an implant, which comprises a wireless receiver for receiving the signal, and at least one electrode, the implant configured to drive the electrode to apply current to an aortic and/or vagal site of the subject in response to the signal. | 05-16-2013 |
20140114377 | VAGUS NERVE STIMULATION - Apparatus and methods are described including identifying a subject as suffering from a condition selected from the group consisting of congestive heart failure, diastolic heart failure, acute myocardial infarction, and hypertension. In response to the identifying, an electrode is placed on a vagus nerve of the subject at a vagal site that is between the upper junction of the left thoracic vagal trunk with the left subclavian artery of the subject, and the thoracic vagal branching into an esophageal plexus of the subject. The subject is treated by electrically stimulating the vagal site by driving a current into the vagal site, via the electrode. Other applications are also described. | 04-24-2014 |
20140324142 | ACUTE MYOCARDIAL INFARCTION TREATMENT BY ELECTRICAL STIMULATION OF THE THORACIC AORTA - Apparatus and methods are described including an electrode device ( | 10-30-2014 |